• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分享和向病情较轻的患者提供“不划算”的延长生命服务。

Sharing and the Provision of "Cost-Ineffective" Life-Extending Services to Less Severely Ill Patients.

机构信息

Centre for Health Economics, Monash Business School, Monash University, Clayton, Victoria, Australia.

Centre for Health Economics, Monash Business School, Monash University, Clayton, Victoria, Australia.

出版信息

Value Health. 2018 Aug;21(8):951-957. doi: 10.1016/j.jval.2017.12.024. Epub 2018 Feb 22.

DOI:10.1016/j.jval.2017.12.024
PMID:30098673
Abstract

BACKGROUND

Cost-utility analysis prioritizes services using cost, life-years, and the health state utility of the life-years. Nevertheless, a significant body of evidence suggests that the public would prefer more variables to be considered in decision making and at least some sharing of the budget with services for severe conditions that are not cost-effective because of their high cost.

OBJECTIVES

To examine whether this preference for sharing persists for less severe conditions when both cost effectiveness and illness severity would indicate that resources should be allocated to other services.

METHODS

Survey respondents were asked to divide a budget between two patients facing life-threatening illnesses. The severity of the illnesses differed and the price of treatment was varied.

RESULTS

Sharing occurred in all scenarios including scenarios in which the illness was less severe and services were not cost-effective. Results are consistent with behavior commonly observed in other contexts.

CONCLUSIONS

Results suggest that sharing per se is important and that the public would support some funding of cost-ineffective services for less severe health problems.

摘要

背景

成本效用分析通过成本、寿命年和寿命年的健康状态效用来优先考虑服务。然而,大量证据表明,公众希望在决策中考虑更多的变量,并至少将部分预算与治疗严重疾病的服务共享,因为这些疾病由于成本高昂而没有成本效益。

目的

当成本效益和疾病严重程度都表明资源应分配给其他服务时,检验这种对较不严重疾病的共享偏好是否仍然存在。

方法

调查受访者被要求在两名面临危及生命的疾病的患者之间分配预算。疾病的严重程度不同,治疗的价格也不同。

结果

在所有情况下都存在共享,包括疾病较轻且服务无成本效益的情况。结果与在其他背景下常见的行为一致。

结论

结果表明,共享本身很重要,公众会支持为较不严重的健康问题提供一些成本效益不佳的服务的资金。

相似文献

1
Sharing and the Provision of "Cost-Ineffective" Life-Extending Services to Less Severely Ill Patients.分享和向病情较轻的患者提供“不划算”的延长生命服务。
Value Health. 2018 Aug;21(8):951-957. doi: 10.1016/j.jval.2017.12.024. Epub 2018 Feb 22.
2
Uncertainty and the Undervaluation of Services for Severe Health States in Cost-Utility Analyses.不确定性与成本效益分析中重度健康状态服务的低估。
Value Health. 2018 Jul;21(7):850-857. doi: 10.1016/j.jval.2017.10.022. Epub 2017 Nov 28.
3
Communal Sharing and the Provision of Low-Volume High-Cost Health Services: Results of a Survey.社区共享与低容量高成本医疗服务的提供:一项调查结果
Pharmacoecon Open. 2017 Mar;1(1):13-23. doi: 10.1007/s41669-016-0002-3.
4
Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.社会对具有相同效率的干预措施的偏好:评估及其在决策中的应用
Appl Health Econ Health Policy. 2016 Jun;14(3):375-85. doi: 10.1007/s40258-016-0236-3.
5
Distributional dilemmas in health policy: large benefits for a few or smaller benefits for many?卫生政策中的分配困境:少数人的巨大利益还是多数人的较小利益?
J Health Serv Res Policy. 1997 Oct;2(4):212-6. doi: 10.1177/135581969700200405.
6
Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4].目标、预算、阈值与机会成本——一种卫生经济学方法:一份药物经济学与结果研究协会(ISPOR)特别工作组报告[4]
Value Health. 2018 Feb;21(2):140-145. doi: 10.1016/j.jval.2017.12.008.
7
Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.第三代芳香化酶抑制剂用于晚期乳腺癌的成本效用和预算影响:基于意大利国家医疗服务体系成本的文献模型分析
Clin Ther. 2004 Sep;26(9):1546-61. doi: 10.1016/j.clinthera.2004.09.014.
8
Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.获取社会对疾病负担和生命末期质量调整生命年(QALY)加权的偏好。
Med Decis Making. 2016 Feb;36(2):210-22. doi: 10.1177/0272989X15619389. Epub 2015 Dec 15.
9
Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.将公共医疗保险覆盖范围扩大至包括验光师进行糖尿病视网膜病变筛查的成本效用分析。
Value Health. 2017 Sep;20(8):1034-1040. doi: 10.1016/j.jval.2017.04.015. Epub 2017 Jun 1.
10
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.

引用本文的文献

1
Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies.罕见病治疗方法的评估:社会偏好研究的系统文献综述。
Adv Ther. 2023 Feb;40(2):393-424. doi: 10.1007/s12325-022-02359-z. Epub 2022 Dec 1.
2
What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK.疾病的哪些方面影响公众对医疗保健优先事项设定的偏好?英国的离散选择实验。
Pharmacoeconomics. 2021 Dec;39(12):1443-1454. doi: 10.1007/s40273-021-01067-w. Epub 2021 Aug 19.
3
Health technology assessment (HTA) and economic evaluation: efficiency or fairness first.
卫生技术评估(HTA)与经济评估:效率优先还是公平优先。
J Mark Access Health Policy. 2018 Dec 20;7(1):1557981. doi: 10.1080/20016689.2018.1557981. eCollection 2019.